IRS Expands Eligible Medical Expenses and Preventive Care Benefits

The IRS Notices 2024-71 and 2024-75 expand eligible expenses for FSAs, HRAs, HSAs, and HDHPs. Employers should update benefit plans.

Nov 19, 2024 3.5 minute read
Upward view of modern skyscrapers with reflective glass facades against a partly cloudy sky.

The IRS recently released updated guidance through Notices 2024-71 and 2024-75, broadening the scope of eligible medical expenses and preventive care under high-deductible health plans (“HDHPs”). This includes certain contraceptive expenses now qualifying as pre-tax medical care and an expanded list of HDHP preventive services that can be covered before meeting the deductible.

Key Compliance Updates:

  • Condoms are now recognized as eligible expenses for reimbursement through health FSAs, HRAs, and HSAs.
  • HDHPs can now cover over-the-counter oral contraceptives, including emergency contraceptives and male condoms, as preventive care prior to meeting the deductible.

Details on the New Guidance

Eligible Expenses under FSAs, HRAs, and HSAs: Under Section 213(d), expenses for medical care—including diagnosis, treatment, and certain preventive measures—are eligible for reimbursement through health flexible spending accounts (“FSAs”), health reimbursement arrangements (“HRAs”), and health savings accounts (“HSAs”). According to Notice 2024-71, condoms are now specifically included as reimbursable medical expenses.

Preventive Care Coverage in HDHPs

Typically, HDHPs require the minimum deductible to be met before benefits apply, except for preventive care. Notice 2024-75 allows HDHPs to cover certain contraceptives (including over-the-counter and emergency options) and condoms before the deductible is met, effective for plan years beginning on or after December 30, 2022. These updates do not affect HSA eligibility.

The notice also confirms:

  • All forms of breast cancer screening for individuals without a breast cancer diagnosis are now preventive care.
  • Continuous glucose monitors are preventive care for individuals with diabetes.
  • Certain insulin products qualify as preventive care, regardless of whether they are for diabetes treatment or prevention of related complications.

Employer Considerations

Employers should consider:

  • Informing employees of these changes if offering an FSA, HRA, or HSA, and consulting with their Section 125/cafeteria plan vendor to update plan documents if necessary.
  • Coordinating with insurance carriers or third-party administrators to ensure HDHP plans incorporate these changes without impacting deductibles.

Further Resources

Contact a Wisterm consultant to learn more about our integrated compliance solutions tailored to enhance your benefits offerings.

Other articles of interest

Employee Benefits
Aerial straight down over Lombard Street with cars and road running horizontally

San Francisco HCSO and FCO Annual Reporting Due by May 2, 2025

San Francisco employers must submit the 2024 HCSO and FCO Employer Annual Reporting Form by May 2, 2025, to avoid penalties and ensure compliance.

Reinsurance
Petri dishes with samples for DNA sequencing

The Impact of Gene Therapy on Self-Funded Health Plans and Medical Stop-Loss Captives

Explore the intersection of gene therapy and self-funded employer health plans that leverage captive insurance arrangements.

Employee Benefits
Business man passing by table

Grandfathered Health Plan Implications and Considerations

Grandfathered health plans under the ACA allow certain existing plans to bypass some ACA requirements, but maintaining this status requires strict adherence to regulations, including limited benefit changes and mandatory participant notices.